Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
HER2-Low 是一种新的临床实体，还是仅仅是抗体药物偶联物的生物标志物？
期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-023-00249-0
Ko, Heidi; Previs, Rebecca A; Strickland, Kyle C; Klein, Jonathan; Caveney, Brian; Chiruzzi, Chiara; Eisenberg, Marcia; Severson, Eric A; Ramkissoon, Shakti; Saini, Kamal S
